| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | TRERF1 NCOA6 DDX17 KAT6A HIPK2 SSBP3 TRIM24 ARID1B KMT2D BRD8 ZMIZ2 SMARCA4 QKI | 4.32e-09 | 303 | 101 | 13 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 NCOA6 DDX17 KAT6A HIPK2 SSBP3 TRIM24 ARID1B KMT2D BRD8 ZMIZ2 SMARCA4 QKI | 5.13e-06 | 562 | 101 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 1.75e-05 | 31 | 101 | 4 | GO:0004181 | |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 2.53e-05 | 2 | 101 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 FLNA NCOA6 KAT6A HIPK2 TRIM24 MEIS2 BPTF ARNT BRD8 THRA ARID2 SMARCA4 DNAJA1 | 2.56e-05 | 753 | 101 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | iron-responsive element binding | 7.57e-05 | 3 | 101 | 2 | GO:0030350 | |
| GeneOntologyMolecularFunction | aconitate hydratase activity | 7.57e-05 | 3 | 101 | 2 | GO:0003994 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 1.10e-04 | 49 | 101 | 4 | GO:0004180 | |
| GeneOntologyMolecularFunction | zinc ion binding | SLC4A8 ZSWIM3 POLR1A KAT6A CPD TRIM24 AGBL3 THRA AARS2 ZMIZ2 NFX1 AGBL1 AGTPBP1 CA1 | 1.55e-04 | 891 | 101 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 2.58e-04 | 61 | 101 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR NCOA6 DDX17 POLR1A KAT6A CHD7 TRIM24 ARID1B THRA GLI3 SMARCA4 MBD5 | 3.53e-04 | 739 | 101 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 3.75e-04 | 6 | 101 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | biotin binding | 3.75e-04 | 6 | 101 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 4.38e-04 | 70 | 101 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 5.23e-04 | 7 | 101 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TRERF1 FLNA NCOA6 KAT6A HIPK2 TRIM24 ARNT BRD8 SMARCA4 DNAJA1 | 7.30e-04 | 582 | 101 | 10 | GO:0140297 |
| GeneOntologyMolecularFunction | transition metal ion binding | SLC4A8 ZSWIM3 POLR1A CYP21A2 KAT6A CPD TRIM24 AGBL3 THRA AARS2 ZMIZ2 NFX1 AGBL1 AGTPBP1 CA1 | 9.16e-04 | 1189 | 101 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | Tat protein binding | 1.11e-03 | 10 | 101 | 2 | GO:0030957 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.26e-03 | 417 | 101 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 TPR NCOA6 DDX17 KAT6A HIPK2 SSBP3 TRIM24 ARID1B KMT2D BRD8 ZMIZ2 SMARCA4 QKI | 2.08e-03 | 1160 | 101 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | aminoacyl-tRNA editing activity | 2.22e-03 | 14 | 101 | 2 | GO:0002161 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 2.36e-03 | 110 | 101 | 4 | GO:0008238 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.62e-03 | 187 | 101 | 5 | GO:0016922 | |
| GeneOntologyBiologicalProcess | protein side chain deglutamylation | 2.19e-06 | 6 | 100 | 3 | GO:0035610 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | TRERF1 DDX17 TRIM24 ARNT KMT2D THRA PPT1 PTPRS SMARCA4 PUM1 DNAJA1 | 5.58e-06 | 416 | 100 | 11 | GO:0030522 |
| GeneOntologyBiologicalProcess | protein deglutamylation | 6.08e-06 | 8 | 100 | 3 | GO:0035608 | |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 2.33e-05 | 2 | 100 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | head development | FLNA NCOA6 KAT6A CHD7 SSBP3 MEIS2 BPTF PPT1 PTPRS GLI3 SEC16A SMARCA4 DNAH5 PCM1 AGTPBP1 | 3.54e-05 | 919 | 100 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 5.78e-05 | 202 | 100 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | brain development | FLNA NCOA6 CHD7 SSBP3 MEIS2 BPTF PPT1 PTPRS GLI3 SEC16A SMARCA4 DNAH5 PCM1 AGTPBP1 | 6.73e-05 | 859 | 100 | 14 | GO:0007420 |
| GeneOntologyBiologicalProcess | tricarboxylic acid metabolic process | 8.56e-05 | 18 | 100 | 3 | GO:0072350 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 NCOA6 DDX17 GLIS3 HIPK2 SSBP2 CHD7 SSBP3 MEIS2 BPTF ARNT KMT2D BRD8 THRA GLI3 ARID2 ZMIZ2 SMARCA4 | 1.13e-04 | 1390 | 100 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.87e-04 | 244 | 100 | 7 | GO:0009755 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.98e-04 | 418 | 100 | 9 | GO:0009895 | |
| GeneOntologyBiologicalProcess | negative regulation of toll-like receptor 9 signaling pathway | 2.31e-04 | 5 | 100 | 2 | GO:0034164 | |
| GeneOntologyBiologicalProcess | citrate metabolic process | 2.31e-04 | 5 | 100 | 2 | GO:0006101 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 2.54e-04 | 116 | 100 | 5 | GO:0008344 | |
| GeneOntologyBiologicalProcess | hemopoiesis | TRAF3IP2 FLNA NCOA6 KAT6A HIPK2 IREB2 CHD7 SSBP3 MEIS2 ARID1B ARNT THRA GLI3 ARID2 SMARCA4 QKI | 2.55e-04 | 1223 | 100 | 16 | GO:0030097 |
| GeneOntologyBiologicalProcess | chemical homeostasis | FLNA NCOA6 SLC4A8 ACACA ACACB ACO1 IREB2 CHD7 SLC30A1 TRIM24 PPT1 SMARCA4 MBD5 NNT FOXK1 UNC80 | 3.22e-04 | 1249 | 100 | 16 | GO:0048878 |
| GeneOntologyBiologicalProcess | C-terminal protein deglutamylation | 3.45e-04 | 6 | 100 | 2 | GO:0035609 | |
| GeneOntologyBiologicalProcess | malonyl-CoA metabolic process | 3.45e-04 | 6 | 100 | 2 | GO:2001293 | |
| GeneOntologyBiologicalProcess | peptidyl-glutamic acid modification | 3.69e-04 | 29 | 100 | 3 | GO:0018200 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 3.69e-04 | 29 | 100 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 3.79e-04 | 558 | 100 | 10 | GO:0030099 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.95e-04 | 561 | 100 | 10 | GO:0048568 | |
| GeneOntologyBiologicalProcess | artery development | 4.77e-04 | 133 | 100 | 5 | GO:0060840 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 7.14e-06 | 96 | 101 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.28e-05 | 30 | 101 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | ATPase complex | 3.86e-05 | 129 | 101 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 TPR FLNA NCOA6 POLR1A WDR33 NUP210L HIPK2 BPTF ARID1B ARNT KMT2D BRD8 THRA ARID2 SMARCA4 CSTF2 BICRAL | 9.70e-05 | 1377 | 101 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | axoneme | 5.09e-04 | 207 | 101 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.22e-04 | 208 | 101 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | perichromatin fibrils | 6.35e-04 | 8 | 101 | 2 | GO:0005726 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 8.79e-04 | 317 | 101 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | fibrillar center | 9.67e-04 | 156 | 101 | 5 | GO:0001650 | |
| GeneOntologyCellularComponent | bBAF complex | 1.01e-03 | 10 | 101 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.48e-03 | 12 | 101 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.48e-03 | 12 | 101 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.82e-03 | 360 | 101 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | npBAF complex | 2.03e-03 | 14 | 101 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 2.03e-03 | 14 | 101 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | dynein complex | 2.27e-03 | 54 | 101 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | RSC-type complex | 2.33e-03 | 15 | 101 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | nBAF complex | 2.65e-03 | 16 | 101 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.71e-03 | 287 | 101 | 6 | GO:0035770 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 3.00e-03 | 293 | 101 | 6 | GO:0030658 | |
| HumanPheno | Prominent eyelashes | 7.97e-06 | 17 | 41 | 4 | HP:0011231 | |
| HumanPheno | Oral aversion | 7.97e-06 | 17 | 41 | 4 | HP:0012523 | |
| HumanPheno | Short 5th finger | 9.88e-06 | 64 | 41 | 6 | HP:0009237 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 1.18e-05 | 66 | 41 | 6 | HP:0006262 | |
| HumanPheno | Aplasia of the toes | 2.30e-05 | 74 | 41 | 6 | HP:0011306 | |
| HumanPheno | Absent toe | 2.30e-05 | 74 | 41 | 6 | HP:0010760 | |
| HumanPheno | Thin upper lip vermilion | TPR KAT6A GLIS3 MEIS2 BPTF ARID1B KMT2D ARID2 SMARCA4 MBD5 UNC80 | 4.98e-05 | 339 | 41 | 11 | HP:0000219 |
| HumanPheno | Thin lips | TPR KAT6A GLIS3 MEIS2 BPTF ARID1B KMT2D ARID2 SMARCA4 MBD5 UNC80 | 4.98e-05 | 339 | 41 | 11 | HP:0000213 |
| HumanPheno | Sandal gap | 1.01e-04 | 96 | 41 | 6 | HP:0001852 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 1.05e-04 | 140 | 41 | 7 | HP:0001991 | |
| HumanPheno | Abnormal 5th finger morphology | TPR FLNA POLR1A CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 | 1.08e-04 | 509 | 41 | 13 | HP:0004207 |
| HumanPheno | Abnormality of the diaphragm | 1.10e-04 | 141 | 41 | 7 | HP:0000775 | |
| HumanPheno | Congenital hypothyroidism | 1.10e-04 | 32 | 41 | 4 | HP:0000851 | |
| HumanPheno | Hypoplastic fifth fingernail | 1.66e-04 | 14 | 41 | 3 | HP:0008398 | |
| HumanPheno | Short finger | 1.84e-04 | 325 | 41 | 10 | HP:0009381 | |
| HumanPheno | Short phalanx of the 5th toe | 1.89e-04 | 3 | 41 | 2 | HP:0100368 | |
| HumanPheno | Hirsutism | 2.61e-04 | 216 | 41 | 8 | HP:0001007 | |
| HumanPheno | Intracranial cystic lesion | 2.87e-04 | 219 | 41 | 8 | HP:0010576 | |
| HumanPheno | Abnormal fourth ventricle morphology | 2.92e-04 | 165 | 41 | 7 | HP:0010950 | |
| HumanPheno | Dilated fourth ventricle | 2.92e-04 | 165 | 41 | 7 | HP:0002198 | |
| HumanPheno | Cerebellar cyst | 3.03e-04 | 166 | 41 | 7 | HP:0002350 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 3.05e-04 | 221 | 41 | 8 | HP:0000932 | |
| HumanPheno | Central nervous system cyst | 3.15e-04 | 222 | 41 | 8 | HP:0030724 | |
| HumanPheno | Broad hallux | 3.19e-04 | 76 | 41 | 5 | HP:0010055 | |
| HumanPheno | Aplasia/Hypoplasia of the hallux | 3.55e-04 | 43 | 41 | 4 | HP:0008362 | |
| HumanPheno | Recurrent otitis media | 3.67e-04 | 227 | 41 | 8 | HP:0000403 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 3.75e-04 | 4 | 41 | 2 | HP:0010343 | |
| HumanPheno | Choanal atresia | 3.95e-04 | 123 | 41 | 6 | HP:0000453 | |
| HumanPheno | Brachydactyly (hand) | FLNA CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 | 4.19e-04 | 430 | 41 | 11 | HP:0100667 |
| HumanPheno | Broad philtrum | 4.24e-04 | 45 | 41 | 4 | HP:0000289 | |
| HumanPheno | Hypoplastic fifth toenail | 4.29e-04 | 19 | 41 | 3 | HP:0011937 | |
| HumanPheno | Thin vermilion border | TPR KAT6A GLIS3 MEIS2 BPTF ARID1B KMT2D ARID2 SMARCA4 MBD5 UNC80 | 4.45e-04 | 433 | 41 | 11 | HP:0000233 |
| HumanPheno | Delayed speech and language development | FLNA POLR1A KAT6A IREB2 ADGRL1 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 CSTF2 MBD5 PUM1 DNAH5 UNC80 AGTPBP1 CCDC40 | 4.60e-04 | 1123 | 41 | 19 | HP:0000750 |
| HumanPheno | Secundum atrial septal defect | 4.62e-04 | 46 | 41 | 4 | HP:0001684 | |
| HumanPheno | Recurrent infections | TRAF3IP2 FLNA POLR1A KAT6A GLIS3 BPTF ARID1B KMT2D CSF2RB GLI3 ARID2 SMARCA4 C4B MBD5 DNAH5 NNT CCDC40 BRWD1 | 4.80e-04 | 1030 | 41 | 18 | HP:0002719 |
| HumanPheno | Aplasia/Hypoplasia of fingers | 4.84e-04 | 366 | 41 | 10 | HP:0006265 | |
| HumanPheno | Recurrent upper respiratory tract infections | 4.90e-04 | 237 | 41 | 8 | HP:0002788 | |
| HumanPheno | Abnormality of dental eruption | 5.34e-04 | 240 | 41 | 8 | HP:0006292 | |
| HumanPheno | Abnormal skull base morphology | 5.64e-04 | 242 | 41 | 8 | HP:0002693 | |
| HumanPheno | Broad toe | 5.98e-04 | 87 | 41 | 5 | HP:0001837 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 6.23e-04 | 5 | 41 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 6.23e-04 | 5 | 41 | 2 | HP:0010342 | |
| HumanPheno | Choanal atresia or stenosis | 6.25e-04 | 134 | 41 | 6 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 6.25e-04 | 134 | 41 | 6 | HP:0000415 | |
| HumanPheno | Pneumonia | 6.46e-04 | 311 | 41 | 9 | HP:0002090 | |
| HumanPheno | Congenital malformation of the great arteries | FLNA POLR1A KAT6A CHD7 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 DNAH5 CCDC40 | 6.50e-04 | 529 | 41 | 12 | HP:0011603 |
| HumanPheno | Patent ductus arteriosus | 6.79e-04 | 382 | 41 | 10 | HP:0001643 | |
| HumanPheno | Abnormal nasopharynx morphology | 6.82e-04 | 249 | 41 | 8 | HP:0001739 | |
| HumanPheno | Abnormal nasal tip morphology | 7.38e-04 | 386 | 41 | 10 | HP:0000436 | |
| HumanPheno | Enlarged posterior fossa | 7.56e-04 | 193 | 41 | 7 | HP:0005445 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | FLNA CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 UNC80 | 7.58e-04 | 538 | 41 | 12 | HP:0005927 |
| HumanPheno | Short philtrum | 7.58e-04 | 253 | 41 | 8 | HP:0000322 | |
| HumanPheno | Abnormality of upper lip vermillion | TPR KAT6A GLIS3 MEIS2 BPTF ARID1B KMT2D ARID2 SMARCA4 MBD5 UNC80 | 8.03e-04 | 464 | 41 | 11 | HP:0011339 |
| HumanPheno | Dandy-Walker malformation | 8.18e-04 | 141 | 41 | 6 | HP:0001305 | |
| HumanPheno | Dislocated radial head | 8.54e-04 | 54 | 41 | 4 | HP:0003083 | |
| HumanPheno | Language impairment | FLNA POLR1A KAT6A IREB2 ADGRL1 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 CSTF2 MBD5 PUM1 DNAH5 UNC80 AGTPBP1 CCDC40 | 8.68e-04 | 1178 | 41 | 19 | HP:0002463 |
| HumanPheno | Papillary thyroid carcinoma | 8.71e-04 | 24 | 41 | 3 | HP:0002895 | |
| HumanPheno | Aspiration pneumonia | 8.94e-04 | 95 | 41 | 5 | HP:0011951 | |
| HumanPheno | Abnormal pharynx morphology | 9.08e-04 | 260 | 41 | 8 | HP:0033151 | |
| HumanPheno | Prenatal growth deficiency | POLR1A KAT6A GLIS3 CHD7 SEC31A TUBGCP6 ARID1B KMT2D GLI3 ARID2 SMARCA4 PUM1 UNC80 | 9.16e-04 | 631 | 41 | 13 | HP:0001515 |
| HumanPheno | Intrauterine growth retardation | POLR1A KAT6A GLIS3 CHD7 SEC31A TUBGCP6 ARID1B KMT2D GLI3 ARID2 SMARCA4 PUM1 UNC80 | 9.16e-04 | 631 | 41 | 13 | HP:0001511 |
| HumanPheno | Prominent interphalangeal joints | 9.29e-04 | 6 | 41 | 2 | HP:0006237 | |
| HumanPheno | Mesomelic leg shortening | 9.29e-04 | 6 | 41 | 2 | HP:0004987 | |
| HumanPheno | Unusual infection | TRAF3IP2 FLNA POLR1A KAT6A GLIS3 BPTF ARID1B KMT2D CSF2RB GLI3 ARID2 SMARCA4 C4B MBD5 DNAH5 NNT CCDC40 BRWD1 | 9.59e-04 | 1088 | 41 | 18 | HP:0032101 |
| HumanPheno | Giant somatosensory evoked potentials | 1.02e-03 | 147 | 41 | 6 | HP:0001312 | |
| HumanPheno | Abnormality of the radial head | 1.05e-03 | 57 | 41 | 4 | HP:0003995 | |
| HumanPheno | Large forehead | 1.11e-03 | 26 | 41 | 3 | HP:0002003 | |
| HumanPheno | Congenital diaphragmatic hernia | 1.13e-03 | 100 | 41 | 5 | HP:0000776 | |
| HumanPheno | Cerebellar malformation | FLNA POLR1A CHD7 ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 AGTPBP1 | 1.20e-03 | 487 | 41 | 11 | HP:0002438 |
| HumanPheno | Thick eyebrow | 1.30e-03 | 154 | 41 | 6 | HP:0000574 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | FLNA CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 UNC80 | 1.31e-03 | 572 | 41 | 12 | HP:0006496 |
| HumanPheno | Abnormal hallux morphology | 1.32e-03 | 212 | 41 | 7 | HP:0001844 | |
| HumanPheno | Hepatoblastoma | 1.38e-03 | 28 | 41 | 3 | HP:0002884 | |
| HumanPheno | Wide nasal base | 1.38e-03 | 28 | 41 | 3 | HP:0012810 | |
| HumanPheno | Absent sperm flagella | 1.38e-03 | 28 | 41 | 3 | HP:0032558 | |
| HumanPheno | Recurrent respiratory infections | TRAF3IP2 FLNA KAT6A ARID1B KMT2D CSF2RB GLI3 ARID2 SMARCA4 C4B DNAH5 CCDC40 BRWD1 | 1.40e-03 | 660 | 41 | 13 | HP:0002205 |
| HumanPheno | Intestinal malrotation | 1.43e-03 | 157 | 41 | 6 | HP:0002566 | |
| HumanPheno | Hemivertebrae | 1.44e-03 | 62 | 41 | 4 | HP:0002937 | |
| HumanPheno | Abnormality of the humeroradial joint | 1.44e-03 | 62 | 41 | 4 | HP:0100744 | |
| HumanPheno | Broad nasal tip | 1.53e-03 | 159 | 41 | 6 | HP:0000455 | |
| HumanPheno | Abnormal eyelash morphology | 1.61e-03 | 284 | 41 | 8 | HP:0000499 | |
| HumanPheno | Brachydactyly | TPR FLNA KAT6A CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 | 1.61e-03 | 670 | 41 | 13 | HP:0001156 |
| HumanPheno | Abnormality of somatosensory evoked potentials | 1.63e-03 | 161 | 41 | 6 | HP:0007377 | |
| HumanPheno | Aplasia involving bones of the extremities | TPR FLNA KAT6A CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 UNC80 | 1.65e-03 | 759 | 41 | 14 | HP:0009825 |
| HumanPheno | Short digit | TPR FLNA KAT6A CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 | 1.66e-03 | 672 | 41 | 13 | HP:0011927 |
| HumanPheno | Abnormal nasal base norphology | 1.69e-03 | 30 | 41 | 3 | HP:0012808 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | TPR FLNA KAT6A CHD7 MEIS2 BPTF ARID1B KMT2D GLI3 ARID2 SMARCA4 MBD5 PUM1 UNC80 | 1.69e-03 | 761 | 41 | 14 | HP:0045060 |
| HumanPheno | Hernia | FLNA POLR1A GLIS3 CHD7 SEC31A MEIS2 ARID1B KMT2D THRA GLI3 ARID2 SMARCA4 | 1.70e-03 | 589 | 41 | 12 | HP:0100790 |
| HumanPheno | Wide nasal bridge | TPR FLNA POLR1A TUBGCP6 BPTF ARID1B KMT2D GLI3 SMARCA4 PUM1 UNC80 | 1.70e-03 | 508 | 41 | 11 | HP:0000431 |
| HumanPheno | Radial head subluxation | 1.72e-03 | 8 | 41 | 2 | HP:0003048 | |
| HumanPheno | Gonadotropin deficiency | 1.72e-03 | 8 | 41 | 2 | HP:0008213 | |
| HumanPheno | Absent tibia | 1.72e-03 | 8 | 41 | 2 | HP:0009556 | |
| HumanPheno | Ventricular septal defect | TPR POLR1A KAT6A CHD7 SEC31A MEIS2 ARID1B KMT2D GLI3 ARID2 SMARCA4 | 1.76e-03 | 510 | 41 | 11 | HP:0001629 |
| MousePheno | abnormal forebrain morphology | NCOA6 HIPK2 IREB2 CHD7 SSBP3 SSPOP ARID1B ARNT KMT2D THRA PPT1 PTPRS GLI3 CGN MBD5 QKI DNAH5 AGTPBP1 CA1 | 2.14e-05 | 1072 | 86 | 19 | MP:0000783 |
| MousePheno | decreased circulating insulin-like growth factor I level | 3.56e-05 | 61 | 86 | 5 | MP:0004701 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 7.93e-05 | 72 | 86 | 5 | MP:0004700 | |
| MousePheno | abnormal diencephalon morphology | 8.80e-05 | 298 | 86 | 9 | MP:0000830 | |
| MousePheno | abnormal insulin-like growth factor I level | 9.64e-05 | 75 | 86 | 5 | MP:0008831 | |
| MousePheno | abnormal brain size | 9.88e-05 | 375 | 86 | 10 | MP:0000771 | |
| MousePheno | abnormal limbic system morphology | 1.06e-04 | 378 | 86 | 10 | MP:0004166 | |
| MousePheno | interrupted aortic arch | 1.14e-04 | 41 | 86 | 4 | MP:0004157 | |
| MousePheno | abnormal telencephalon morphology | NCOA6 IREB2 CHD7 SSBP3 SSPOP ARID1B KMT2D THRA PPT1 PTPRS GLI3 QKI DNAH5 AGTPBP1 CA1 | 1.15e-04 | 812 | 86 | 15 | MP:0000787 |
| MousePheno | interrupted aorta | 1.37e-04 | 43 | 86 | 4 | MP:0010544 | |
| MousePheno | absent olfactory bulb | 1.44e-04 | 17 | 86 | 3 | MP:0003451 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 1.72e-04 | 18 | 86 | 3 | MP:0011395 | |
| MousePheno | abnormal hippocampus morphology | 1.94e-04 | 331 | 86 | 9 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 2.22e-04 | 337 | 86 | 9 | MP:0000801 | |
| Domain | BROMODOMAIN_1 | 1.37e-06 | 37 | 98 | 5 | PS00633 | |
| Domain | Bromodomain | 1.57e-06 | 38 | 98 | 5 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.32e-06 | 41 | 98 | 5 | PS50014 | |
| Domain | Bromodomain | 2.62e-06 | 42 | 98 | 5 | IPR001487 | |
| Domain | BROMO | 2.62e-06 | 42 | 98 | 5 | SM00297 | |
| Domain | - | 2.62e-06 | 42 | 98 | 5 | 1.20.920.10 | |
| Domain | Peptidase_M14 | 5.85e-06 | 23 | 98 | 4 | PF00246 | |
| Domain | Peptidase_M14 | 5.85e-06 | 23 | 98 | 4 | IPR000834 | |
| Domain | Bromodomain_CS | 9.75e-06 | 26 | 98 | 4 | IPR018359 | |
| Domain | ACC_central | 2.73e-05 | 2 | 98 | 2 | PF08326 | |
| Domain | Aconitase/IRP2 | 2.73e-05 | 2 | 98 | 2 | IPR006249 | |
| Domain | AcCoA_COase_cen | 2.73e-05 | 2 | 98 | 2 | IPR013537 | |
| Domain | Znf_PHD-finger | 5.95e-05 | 79 | 98 | 5 | IPR019787 | |
| Domain | AconitaseA/IPMdHydase_ssu_swvl | 8.15e-05 | 3 | 98 | 2 | IPR000573 | |
| Domain | Aconitase_C | 8.15e-05 | 3 | 98 | 2 | PF00694 | |
| Domain | - | 8.15e-05 | 3 | 98 | 2 | 3.30.499.10 | |
| Domain | Acoase/IPM_deHydtase_lsu_aba | 8.15e-05 | 3 | 98 | 2 | IPR001030 | |
| Domain | - | 8.15e-05 | 3 | 98 | 2 | 3.40.1060.10 | |
| Domain | - | 8.15e-05 | 3 | 98 | 2 | 3.20.19.10 | |
| Domain | Acoase/IPM_deHydtase | 8.15e-05 | 3 | 98 | 2 | IPR015937 | |
| Domain | Acnase/IPM_dHydase_lsu_aba_1/3 | 8.15e-05 | 3 | 98 | 2 | IPR015931 | |
| Domain | Aconitase/IPMdHydase_lsu_aba_2 | 8.15e-05 | 3 | 98 | 2 | IPR015932 | |
| Domain | Sec16_C | 8.15e-05 | 3 | 98 | 2 | PF12931 | |
| Domain | ACONITASE_1 | 8.15e-05 | 3 | 98 | 2 | PS00450 | |
| Domain | Aconitase/3IPM_dehydase_swvl | 8.15e-05 | 3 | 98 | 2 | IPR015928 | |
| Domain | Aconitase | 8.15e-05 | 3 | 98 | 2 | PF00330 | |
| Domain | SSDP_DNA-bd | 8.15e-05 | 3 | 98 | 2 | IPR008116 | |
| Domain | Aconitase_4Fe-4S_BS | 8.15e-05 | 3 | 98 | 2 | IPR018136 | |
| Domain | ACE1_Sec16_Sec31 | 8.15e-05 | 3 | 98 | 2 | IPR024298 | |
| Domain | ACONITASE_2 | 8.15e-05 | 3 | 98 | 2 | PS01244 | |
| Domain | Carboxyl_trans | 1.62e-04 | 4 | 98 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 1.62e-04 | 4 | 98 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 1.62e-04 | 4 | 98 | 2 | PS50980 | |
| Domain | COA_CT_N | 1.62e-04 | 4 | 98 | 2 | IPR011762 | |
| Domain | COA_CT_C | 1.62e-04 | 4 | 98 | 2 | IPR011763 | |
| Domain | Carboxyl_trans | 1.62e-04 | 4 | 98 | 2 | IPR000022 | |
| Domain | Biotin_BS | 2.70e-04 | 5 | 98 | 2 | IPR001882 | |
| Domain | Biotin_COase_C | 2.70e-04 | 5 | 98 | 2 | IPR005482 | |
| Domain | BC | 2.70e-04 | 5 | 98 | 2 | PS50979 | |
| Domain | Biotin_carb_C | 2.70e-04 | 5 | 98 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 2.70e-04 | 5 | 98 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 2.70e-04 | 5 | 98 | 2 | IPR011764 | |
| Domain | CPSASE_1 | 2.70e-04 | 5 | 98 | 2 | PS00866 | |
| Domain | BIOTIN | 2.70e-04 | 5 | 98 | 2 | PS00188 | |
| Domain | BRK | 4.03e-04 | 6 | 98 | 2 | SM00592 | |
| Domain | BRK_domain | 4.03e-04 | 6 | 98 | 2 | IPR006576 | |
| Domain | Rudment_hybrid_motif | 4.03e-04 | 6 | 98 | 2 | IPR011054 | |
| Domain | CPSASE_2 | 4.03e-04 | 6 | 98 | 2 | PS00867 | |
| Domain | BRK | 4.03e-04 | 6 | 98 | 2 | PF07533 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 5.63e-04 | 7 | 98 | 2 | IPR005479 | |
| Domain | BC-like_N | 5.63e-04 | 7 | 98 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 5.63e-04 | 7 | 98 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 5.63e-04 | 7 | 98 | 2 | PF00289 | |
| Domain | PHD | 6.51e-04 | 75 | 98 | 4 | PF00628 | |
| Domain | DHC_N1 | 7.48e-04 | 8 | 98 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.48e-04 | 8 | 98 | 2 | IPR013594 | |
| Domain | Biotin_lipoyl | 9.58e-04 | 9 | 98 | 2 | PF00364 | |
| Domain | BIOTINYL_LIPOYL | 1.19e-03 | 10 | 98 | 2 | PS50968 | |
| Domain | Biotin_lipoyl | 1.19e-03 | 10 | 98 | 2 | IPR000089 | |
| Domain | PHD | 1.24e-03 | 89 | 98 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.34e-03 | 91 | 98 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.57e-03 | 95 | 98 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.64e-03 | 96 | 98 | 4 | PS01359 | |
| Domain | Single_hybrid_motif | 1.74e-03 | 12 | 98 | 2 | IPR011053 | |
| Domain | - | 2.05e-03 | 13 | 98 | 2 | 3.40.50.20 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.38e-03 | 14 | 98 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.38e-03 | 14 | 98 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.38e-03 | 14 | 98 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.38e-03 | 14 | 98 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.38e-03 | 14 | 98 | 2 | IPR011704 | |
| Domain | ATP_GRASP | 2.38e-03 | 14 | 98 | 2 | PS50975 | |
| Domain | ATP-grasp | 2.38e-03 | 14 | 98 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 2.38e-03 | 14 | 98 | 2 | IPR016185 | |
| Domain | MT | 2.38e-03 | 14 | 98 | 2 | PF12777 | |
| Domain | AAA_8 | 2.38e-03 | 14 | 98 | 2 | PF12780 | |
| Domain | AAA_5 | 2.38e-03 | 14 | 98 | 2 | PF07728 | |
| Domain | DHC_fam | 2.74e-03 | 15 | 98 | 2 | IPR026983 | |
| Domain | - | 2.74e-03 | 15 | 98 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 2.74e-03 | 15 | 98 | 2 | SM00501 | |
| Domain | ARID_dom | 2.74e-03 | 15 | 98 | 2 | IPR001606 | |
| Domain | ARID | 2.74e-03 | 15 | 98 | 2 | PS51011 | |
| Domain | Dynein_heavy | 2.74e-03 | 15 | 98 | 2 | PF03028 | |
| Domain | ARID | 2.74e-03 | 15 | 98 | 2 | PF01388 | |
| Domain | Dynein_heavy_dom | 2.74e-03 | 15 | 98 | 2 | IPR004273 | |
| Domain | - | 2.74e-03 | 15 | 98 | 2 | 3.30.1490.20 | |
| Domain | EMI | 3.52e-03 | 17 | 98 | 2 | PS51041 | |
| Domain | ATP_grasp_subdomain_1 | 3.95e-03 | 18 | 98 | 2 | IPR013815 | |
| Domain | - | 3.95e-03 | 18 | 98 | 2 | 3.30.470.20 | |
| Domain | CARBOXYPEPT_ZN_2 | 4.40e-03 | 19 | 98 | 2 | PS00133 | |
| Domain | Zinc_finger_PHD-type_CS | 4.84e-03 | 65 | 98 | 3 | IPR019786 | |
| Domain | CARBOXYPEPT_ZN_1 | 4.87e-03 | 20 | 98 | 2 | PS00132 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.05e-05 | 29 | 80 | 4 | M48076 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.51e-05 | 37 | 80 | 4 | M27797 | |
| Pubmed | TRERF1 NCOA6 ACACB WDR33 LARS1 HIPK2 SSBP2 CHD7 SSBP3 ANKHD1 TRIM24 BPTF ARID1B ARNT KMT2D BRD8 EIF4ENIF1 ZKSCAN1 GLI3 ARID2 ZMIZ2 SEC16A SMARCA4 CSTF2 HELZ PUM1 QKI DNAJA1 FOXK1 PCM1 | 6.52e-18 | 1429 | 102 | 30 | 35140242 | |
| Pubmed | EP400P1 KAT6A FASTKD5 ANKHD1 TRIM24 TUBGCP6 BPTF ARID1B BRD8 THRA EIF4ENIF1 GLI3 ARID2 SEC16A SMARCA4 HELZ BICRAL DNAJA1 AGBL1 FOXK1 UNC80 PCM1 AGTPBP1 BRWD1 | 1.40e-14 | 1116 | 102 | 24 | 31753913 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TPR NCOA6 WDR33 GLIS3 ANKHD1 SLC30A1 TRIM24 ARID1B ARNT KMT2D EIF4ENIF1 FAM222B SEC16A HELZ PUM1 PSPC1 FOXK1 | 2.66e-14 | 457 | 102 | 17 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 NCOA6 ACACB SSBP2 CHD7 TRIM24 BPTF ARID1B ARNT KMT2D ARID2 ZMIZ2 SEC16A SMARCA4 FOXK1 | 1.34e-13 | 351 | 102 | 15 | 38297188 |
| Pubmed | TPR FLNA NCOA6 ACACA WDR33 ANKHD1 BPTF ARID1B KMT2D BRD8 ARID2 CGN SEC16A SMARCA4 CSTF2 PCM1 | 6.51e-12 | 549 | 102 | 16 | 38280479 | |
| Pubmed | TRERF1 TPR FLNA ACACA ACACB CHD7 ANKHD1 TRIM24 KMT2D LMAN1 EIF4ENIF1 ZMIZ2 SEC16A PCM1 | 2.41e-11 | 418 | 102 | 14 | 34709266 | |
| Pubmed | TRERF1 FLNA NCOA6 DDX17 LARS1 CHD7 TRIM24 BPTF ARID1B ARNT KMT2D LMAN1 ARID2 ZMIZ2 SMARCA4 BICRAL QKI PSPC1 FOXK1 PCM1 | 6.33e-11 | 1103 | 102 | 20 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA NCOA6 ACACA KAT6A ADGRL1 SFI1 ANKHD1 FHIP1B ESRP2 HIVEP3 KMT2D EIF4ENIF1 PTPRS ZMIZ2 SEC16A NFX1 DISP2 MBD5 PUM1 FOXK1 | 6.54e-11 | 1105 | 102 | 20 | 35748872 |
| Pubmed | 1.36e-10 | 83 | 102 | 8 | 28794006 | ||
| Pubmed | TRERF1 NCOA6 WDR33 SSBP2 CHD7 TRIM24 ARID1B KMT2D BRD8 SMARCA4 FOXK1 | 4.44e-10 | 268 | 102 | 11 | 33640491 | |
| Pubmed | TPR FLNA POLR1A ACACA CHD7 ANKHD1 BPTF CGN SEC16A SMARCA4 HELZ PUM1 DNAJA1 NNT PCM1 | 8.38e-10 | 653 | 102 | 15 | 22586326 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.07e-09 | 220 | 102 | 10 | 35785414 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | CHD7 TRIM24 ARID1B KMT2D AARS2 ARID2 ZMIZ2 SEC16A SMARCA4 BICRAL DNAJA1 FOXK1 | 2.29e-09 | 398 | 102 | 12 | 35016035 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR FLNA NCOA6 DDX17 WDR33 CHD7 TRIM24 BPTF ARID1B BRD8 ARID2 SEC16A SMARCA4 CSTF2 PUM1 PSPC1 PCM1 | 2.64e-09 | 954 | 102 | 17 | 36373674 |
| Pubmed | POLR1A WDR33 FASTKD5 CHD7 SLC30A1 ARID1B EIF4ENIF1 SEC16A SMARCA4 CSTF2 HELZ PUM1 DNAJA1 PCM1 AGTPBP1 | 3.99e-09 | 733 | 102 | 15 | 34672954 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 TPR FLNA NCOA6 ACACA CHD7 TUBGCP6 BPTF KMT2D BRD8 SEC16A SMARCA4 HELZ PCM1 AGTPBP1 | 8.25e-09 | 774 | 102 | 15 | 15302935 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DDX17 POLR1A ACACA WDR33 LARS1 SEC31A SSBP3 ANKHD1 TRIM24 AARS2 SMARCA4 DNAJA1 DNAH5 DNAH8 | 1.97e-08 | 704 | 102 | 14 | 29955894 |
| Pubmed | 2.21e-08 | 157 | 102 | 8 | 30186101 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR FLNA DDX17 POLR1A LARS1 BPTF AARS2 CGN SEC16A SMARCA4 CSTF2 PUM1 DNAJA1 PSPC1 NNT PCM1 | 5.04e-08 | 1024 | 102 | 16 | 24711643 |
| Pubmed | TRERF1 FLNA DDX17 ACACA LARS1 ANKHD1 EIF4ENIF1 SEC16A HELZ SPATS2 PUM1 DNAJA1 PSPC1 | 6.72e-08 | 655 | 102 | 13 | 35819319 | |
| Pubmed | TRERF1 GLIS3 TRIM24 MEIS2 HIVEP3 BPTF ARNT BRD8 THRA ZKSCAN1 GLI3 ARID2 ZMIZ2 FOXK1 | 1.07e-07 | 808 | 102 | 14 | 20412781 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.61e-07 | 203 | 102 | 8 | 22083510 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA POLR1A ACACA SEC31A ANKHD1 EIF4ENIF1 NFX1 HELZ SPATS2 PUM1 DNAJA1 NNT AGTPBP1 | 2.12e-07 | 724 | 102 | 13 | 36232890 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR LARS1 ANKHD1 TRIM24 ESRP2 BPTF ARNT KMT2D BRD8 AARS2 SMARCA4 PUM1 FOXK1 AGTPBP1 | 2.19e-07 | 857 | 102 | 14 | 25609649 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.63e-07 | 146 | 102 | 7 | 23892456 | |
| Pubmed | TPR FLNA ZSWIM3 ACACA FASTKD5 SEC31A MEIS2 ARNT BRD8 THRA GLI3 ARID2 SEC16A HELZ DNAJA1 FOXK1 PCM1 | 3.11e-07 | 1327 | 102 | 17 | 32694731 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EP400P1 POLR1A ACACA KAT6A HIPK2 ADGRL1 CPD SSBP3 CCDC57 SSPOP HIVEP3 BPTF PTPN4 THRA PTPRS SPATS2 MBD5 PCM1 | 3.13e-07 | 1489 | 102 | 18 | 28611215 |
| Pubmed | 3.46e-07 | 152 | 102 | 7 | 38360978 | ||
| Pubmed | 4.74e-07 | 234 | 102 | 8 | 36243803 | ||
| Pubmed | 4.87e-07 | 6 | 102 | 3 | 17244818 | ||
| Pubmed | 4.87e-07 | 6 | 102 | 3 | 25103237 | ||
| Pubmed | 4.87e-07 | 6 | 102 | 3 | 16952463 | ||
| Pubmed | FLNA WDR33 IREB2 CHD7 ANKHD1 TMEM263 AFP CGN SEC16A NFX1 SMARCA4 C4B SPATS2 QKI PSPC1 PCM1 AGTPBP1 | 4.90e-07 | 1371 | 102 | 17 | 36244648 | |
| Pubmed | 6.21e-07 | 332 | 102 | 9 | 37433992 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FLNA DDX17 WDR33 FASTKD5 ANKHD1 ESRP2 EIF4ENIF1 NFX1 CSTF2 HELZ PUM1 QKI PSPC1 | 7.19e-07 | 807 | 102 | 13 | 22681889 |
| Pubmed | 1.16e-06 | 27 | 102 | 4 | 29374058 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.16e-06 | 182 | 102 | 7 | 32239614 | |
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 1.36e-06 | 8 | 102 | 3 | 20130577 | |
| Pubmed | 1.57e-06 | 29 | 102 | 4 | 31330130 | ||
| Pubmed | FLNA DDX17 POLR1A ANKHD1 AARS2 SEC16A NFX1 SMARCA4 PUM1 DNAJA1 PSPC1 | 1.61e-06 | 601 | 102 | 11 | 33658012 | |
| Pubmed | 1.92e-06 | 282 | 102 | 8 | 23667531 | ||
| Pubmed | 2.03e-06 | 9 | 102 | 3 | 26829768 | ||
| Pubmed | 2.03e-06 | 9 | 102 | 3 | 23556151 | ||
| Pubmed | 2.03e-06 | 9 | 102 | 3 | 37805104 | ||
| Pubmed | FLNA DDX17 ACACA NUP210L LARS1 SEC31A TRIM24 TMEM263 SEC16A SMARCA4 PUM1 PSPC1 | 2.25e-06 | 754 | 102 | 12 | 35906200 | |
| Pubmed | CPD SLC30A1 PTPN4 ARID1B KMT2D LMAN1 PTPRS CGN SEC16A CSTF2 HELZ PUM1 DNAJA1 AGTPBP1 | 2.39e-06 | 1049 | 102 | 14 | 27880917 | |
| Pubmed | 2.65e-06 | 396 | 102 | 9 | 26687479 | ||
| Pubmed | 2.82e-06 | 399 | 102 | 9 | 37536630 | ||
| Pubmed | 2.82e-06 | 399 | 102 | 9 | 35987950 | ||
| Pubmed | 2.88e-06 | 75 | 102 | 5 | 25593309 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 2.90e-06 | 10 | 102 | 3 | 23129809 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | TPR FLNA DDX17 WDR33 SSBP3 TMEM263 ARID1B SEC16A CSTF2 HELZ PUM1 DNAJA1 PSPC1 | 3.12e-06 | 922 | 102 | 13 | 27609421 |
| Pubmed | 3.50e-06 | 78 | 102 | 5 | 28611094 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR FLNA DDX17 POLR1A ACACA LARS1 FASTKD5 SEC31A ANKHD1 LMAN1 SMARCA4 PUM1 DNAJA1 PSPC1 DNAH5 NNT | 3.96e-06 | 1425 | 102 | 16 | 30948266 |
| Pubmed | 3.97e-06 | 80 | 102 | 5 | 35803934 | ||
| Pubmed | 4.03e-06 | 534 | 102 | 10 | 35032548 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TPR DDX17 ACACA ACACB LARS1 SEC31A SMARCA4 CSTF2 DNAJA1 FOXK1 PCM1 | 4.24e-06 | 665 | 102 | 11 | 30457570 |
| Pubmed | Interplay of BAF and MLL4 promotes cell type-specific enhancer activation. | 5.29e-06 | 12 | 102 | 3 | 33712604 | |
| Pubmed | SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | 5.29e-06 | 12 | 102 | 3 | 31911863 | |
| Pubmed | IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development. | 5.29e-06 | 12 | 102 | 3 | 28794449 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 5.79e-06 | 232 | 102 | 7 | 25515538 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.38e-06 | 332 | 102 | 8 | 32786267 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA DDX17 POLR1A ACACA ACACB LARS1 FASTKD5 CHD7 LMAN1 SEC16A SMARCA4 HELZ PUM1 PSPC1 CA1 | 6.99e-06 | 1318 | 102 | 15 | 30463901 |
| Pubmed | 7.30e-06 | 449 | 102 | 9 | 31732153 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.75e-06 | 341 | 102 | 8 | 32971831 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACA ACACB CPD FHIP1B CCDC57 EIF4ENIF1 CGN NFX1 FAM83G DNAJA1 PCM1 BRWD1 | 7.86e-06 | 853 | 102 | 12 | 28718761 |
| Pubmed | Subcellular localization of iron regulatory proteins to Golgi and ER membranes. | 8.52e-06 | 2 | 102 | 2 | 16144863 | |
| Pubmed | Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. | 8.52e-06 | 2 | 102 | 2 | 15866737 | |
| Pubmed | De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. | 8.52e-06 | 2 | 102 | 2 | 25282359 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27693630 | ||
| Pubmed | A regulated RNA binding protein also possesses aconitase activity. | 8.52e-06 | 2 | 102 | 2 | 1946430 | |
| Pubmed | Generation of conditional alleles of the murine Iron Regulatory Protein (IRP)-1 and -2 genes. | 8.52e-06 | 2 | 102 | 2 | 16283625 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 38301068 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 14726953 | ||
| Pubmed | Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins. | 8.52e-06 | 2 | 102 | 2 | 17200797 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32215608 | ||
| Pubmed | Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor. | 8.52e-06 | 2 | 102 | 2 | 29772612 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29976587 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24944901 | ||
| Pubmed | In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation. | 8.52e-06 | 2 | 102 | 2 | 19533074 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15831703 | ||
| Pubmed | Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins. | 8.52e-06 | 2 | 102 | 2 | 25771171 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15208438 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8262972 | ||
| Pubmed | Structure and regulation of acetyl-CoA carboxylase genes of metazoa. | 8.52e-06 | 2 | 102 | 2 | 15749055 | |
| Pubmed | Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. | 8.52e-06 | 2 | 102 | 2 | 20139635 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16503547 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21566147 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28081256 | ||
| Pubmed | Self-association and ligand-induced conformational changes of iron regulatory proteins 1 and 2. | 8.52e-06 | 2 | 102 | 2 | 15938636 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26976583 | ||
| Pubmed | Iron regulatory proteins secure mitochondrial iron sufficiency and function. | 8.52e-06 | 2 | 102 | 2 | 20674864 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28475860 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17604281 | ||
| Pubmed | Expression of the Wdr9 gene and protein products during mouse development. | 8.52e-06 | 2 | 102 | 2 | 12889071 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29433631 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18179706 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 2172968 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22331484 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 7983023 | ||
| Interaction | AR interactions | TRERF1 TPR FLNA NCOA6 DDX17 WDR33 HIPK2 SSBP2 CHD7 TRIM24 ARID1B ARNT KMT2D BRD8 GLI3 ARID2 ZMIZ2 CGN SEC16A SMARCA4 DNAJA1 PSPC1 FOXK1 PCM1 | 1.08e-10 | 992 | 102 | 24 | int:AR |
| Interaction | NUP35 interactions | NCOA6 WDR33 GLIS3 ANKHD1 TRIM24 HIVEP3 ARID1B ARNT KMT2D EIF4ENIF1 FAM222B SEC16A HELZ PUM1 PSPC1 FOXK1 | 4.04e-10 | 424 | 102 | 16 | int:NUP35 |
| Interaction | SP7 interactions | TRERF1 NCOA6 WDR33 CHD7 SSBP3 TRIM24 ARID1B ARNT KMT2D ARID2 ZMIZ2 SMARCA4 QKI FOXK1 | 4.24e-10 | 304 | 102 | 14 | int:SP7 |
| Interaction | SOX2 interactions | TRERF1 FLNA NCOA6 DDX17 LARS1 GLIS3 CHD7 SSBP3 ANKHD1 TRIM24 MEIS2 BPTF ARID1B ARNT KMT2D BRD8 PPT1 GLI3 ARID2 ZMIZ2 SEC16A SMARCA4 HELZ SPATS2 QKI DNAJA1 FOXK1 | 1.30e-09 | 1422 | 102 | 27 | int:SOX2 |
| Interaction | TLE3 interactions | TRERF1 TRAF3IP2 FLNA DDX17 ARID1B ARNT KMT2D BRD8 ARID2 ZMIZ2 SMARCA4 CSTF2 HELZ QKI | 6.55e-09 | 376 | 102 | 14 | int:TLE3 |
| Interaction | EGR2 interactions | TRERF1 NCOA6 SSBP2 CHD7 TRIM24 ARID1B KMT2D ARID2 ZMIZ2 SEC16A | 1.62e-08 | 171 | 102 | 10 | int:EGR2 |
| Interaction | TBXT interactions | 1.32e-07 | 116 | 102 | 8 | int:TBXT | |
| Interaction | NANOG interactions | TRERF1 ACACB WDR33 CHD7 SSBP3 TRIM24 BPTF ARID1B ARNT BRD8 SEC16A SMARCA4 PUM1 DNAJA1 | 1.41e-07 | 481 | 102 | 14 | int:NANOG |
| Interaction | LHX4 interactions | 1.67e-07 | 166 | 102 | 9 | int:LHX4 | |
| Interaction | PHF21A interactions | TPR FLNA ACACA ACACB CHD7 ANKHD1 KMT2D LMAN1 EIF4ENIF1 ZMIZ2 SEC16A PCM1 | 1.67e-07 | 343 | 102 | 12 | int:PHF21A |
| Interaction | SOX7 interactions | 1.92e-07 | 82 | 102 | 7 | int:SOX7 | |
| Interaction | TOP3B interactions | FLNA NCOA6 ACACA KAT6A LARS1 IREB2 ADGRL1 SFI1 ANKHD1 FHIP1B ESRP2 HIVEP3 KMT2D EIF4ENIF1 PTPRS ZMIZ2 SEC16A NFX1 HELZ DISP2 MBD5 PUM1 DNAJA1 FOXK1 | 2.29e-07 | 1470 | 102 | 24 | int:TOP3B |
| Interaction | CREBBP interactions | TRERF1 NCOA6 DDX17 KAT6A HIPK2 TRIM24 ARID1B ARNT KMT2D THRA EIF4ENIF1 AFP GLI3 SMARCA4 HELZ | 3.36e-07 | 599 | 102 | 15 | int:CREBBP |
| Interaction | ALG13 interactions | 3.82e-07 | 183 | 102 | 9 | int:ALG13 | |
| Interaction | LHX2 interactions | 3.82e-07 | 183 | 102 | 9 | int:LHX2 | |
| Interaction | CRX interactions | 6.53e-07 | 254 | 102 | 10 | int:CRX | |
| Interaction | SS18L1 interactions | 6.56e-07 | 98 | 102 | 7 | int:SS18L1 | |
| Interaction | GATA2 interactions | 7.73e-07 | 199 | 102 | 9 | int:GATA2 | |
| Interaction | FEV interactions | 9.12e-07 | 203 | 102 | 9 | int:FEV | |
| Interaction | LHX1 interactions | 9.20e-07 | 103 | 102 | 7 | int:LHX1 | |
| Interaction | RCOR1 interactions | TPR FLNA ACACA ACACB CHD7 ANKHD1 KMT2D LMAN1 EIF4ENIF1 SEC16A SMARCA4 DNAJA1 PCM1 | 1.26e-06 | 494 | 102 | 13 | int:RCOR1 |
| Interaction | ETV4 interactions | 1.34e-06 | 69 | 102 | 6 | int:ETV4 | |
| Interaction | HNF4A interactions | 1.34e-06 | 275 | 102 | 10 | int:HNF4A | |
| Interaction | POU5F1 interactions | TPR FLNA ACACB WDR33 FASTKD5 CHD7 TRIM24 BPTF ARID1B SMARCA4 HELZ DNAJA1 PSPC1 BRWD1 | 1.44e-06 | 584 | 102 | 14 | int:POU5F1 |
| Interaction | WWTR1 interactions | NCOA6 ANKHD1 BPTF ARID1B ARNT KMT2D ARID2 CGN SEC16A SMARCA4 CSTF2 PCM1 | 1.50e-06 | 422 | 102 | 12 | int:WWTR1 |
| Interaction | DUXB interactions | 1.79e-06 | 18 | 102 | 4 | int:DUXB | |
| Interaction | ERG interactions | 1.99e-06 | 223 | 102 | 9 | int:ERG | |
| Interaction | PAX6 interactions | NCOA6 HIPK2 CHD7 TRIM24 MEIS2 BPTF ARID1B KMT2D ARID2 SMARCA4 FOXK1 | 2.48e-06 | 366 | 102 | 11 | int:PAX6 |
| Interaction | SMC5 interactions | TPR FLNA NCOA6 DDX17 ACACA WDR33 CHD7 TRIM24 BPTF ARID1B BRD8 ARID2 SEC16A SMARCA4 CSTF2 PUM1 PSPC1 PCM1 | 2.49e-06 | 1000 | 102 | 18 | int:SMC5 |
| Interaction | SMAD3 interactions | FLNA NCOA6 KAT6A HIPK2 TRIM24 BPTF ARID1B EIF4ENIF1 GLI3 SMARCA4 FAM83G PSPC1 | 2.72e-06 | 447 | 102 | 12 | int:SMAD3 |
| Interaction | TLX1 interactions | 3.02e-06 | 175 | 102 | 8 | int:TLX1 | |
| Interaction | TEAD1 interactions | 3.15e-06 | 176 | 102 | 8 | int:TEAD1 | |
| Interaction | CNOT2 interactions | 3.42e-06 | 178 | 102 | 8 | int:CNOT2 | |
| Interaction | CEBPA interactions | TRERF1 FLNA NCOA6 DDX17 LARS1 CHD7 TRIM24 BPTF ARID1B ARNT KMT2D LMAN1 ARID2 ZMIZ2 SMARCA4 BICRAL QKI PSPC1 FOXK1 PCM1 | 3.62e-06 | 1245 | 102 | 20 | int:CEBPA |
| Interaction | MEX3A interactions | FLNA DDX17 ADM2 KAT6A EIF4ENIF1 SEC16A SMARCA4 PUM1 DNAH5 FOXK1 PCM1 | 3.94e-06 | 384 | 102 | 11 | int:MEX3A |
| Interaction | FOS interactions | NCOA6 DDX17 ACACB ANKHD1 TRIM24 ARID1B ARNT KMT2D ARID2 SMARCA4 | 4.15e-06 | 312 | 102 | 10 | int:FOS |
| Interaction | PAX9 interactions | 4.39e-06 | 130 | 102 | 7 | int:PAX9 | |
| Interaction | LHX3 interactions | 4.55e-06 | 185 | 102 | 8 | int:LHX3 | |
| Interaction | IRF4 interactions | 4.59e-06 | 85 | 102 | 6 | int:IRF4 | |
| Interaction | SIRT7 interactions | TPR FLNA POLR1A ACACA CHD7 ANKHD1 BPTF CGN SEC16A SMARCA4 HELZ PUM1 DNAJA1 NNT PCM1 | 4.93e-06 | 744 | 102 | 15 | int:SIRT7 |
| Interaction | SMG7 interactions | NCOA6 TRIM24 ARID1B ARNT KMT2D EIF4ENIF1 SEC16A HELZ PUM1 PCM1 | 5.05e-06 | 319 | 102 | 10 | int:SMG7 |
| Interaction | FUS interactions | NCOA6 DDX17 ACACA WDR33 LARS1 ESRP2 HIVEP3 THRA PPT1 ARID2 NFX1 SMARCA4 CSTF2 PSPC1 PCM1 | 6.08e-06 | 757 | 102 | 15 | int:FUS |
| Interaction | SOX17 interactions | 8.75e-06 | 95 | 102 | 6 | int:SOX17 | |
| Interaction | SOX9 interactions | 9.87e-06 | 97 | 102 | 6 | int:SOX9 | |
| Interaction | HDAC1 interactions | TRERF1 TPR FLNA DDX17 ACACA ACACB ANKHD1 BPTF ARNT KMT2D LMAN1 EIF4ENIF1 GLI3 ZMIZ2 SMARCA4 DNAJA1 FOXK1 PCM1 | 1.03e-05 | 1108 | 102 | 18 | int:HDAC1 |
| Interaction | TNRC6A interactions | 1.26e-05 | 280 | 102 | 9 | int:TNRC6A | |
| Interaction | AGO3 interactions | 1.28e-05 | 153 | 102 | 7 | int:AGO3 | |
| Interaction | BAG2 interactions | NCOA6 ANKHD1 TUBGCP6 ESRP2 BPTF ARNT BRD8 LMAN1 EIF4ENIF1 PUM1 QKI DNAJA1 FOXK1 | 1.53e-05 | 622 | 102 | 13 | int:BAG2 |
| Interaction | NUP43 interactions | FLNA NCOA6 DDX17 ACACA ACACB CCDC168 BPTF ARID1B KMT2D BRD8 EIF4ENIF1 ARID2 SMARCA4 | 1.61e-05 | 625 | 102 | 13 | int:NUP43 |
| Interaction | PRRC2C interactions | 1.66e-05 | 290 | 102 | 9 | int:PRRC2C | |
| Interaction | TLX3 interactions | 1.71e-05 | 291 | 102 | 9 | int:TLX3 | |
| Interaction | ATXN1 interactions | TPR DDX17 ACACA ACACB KAT6A LARS1 SEC31A ANKHD1 EIF4ENIF1 SMARCA4 CSTF2 BICRAL PUM1 QKI DNAJA1 FOXK1 PCM1 | 1.71e-05 | 1039 | 102 | 17 | int:ATXN1 |
| Interaction | SNRNP40 interactions | FLNA DDX17 ACACA ACACB KAT6A TRIM24 ARID1B ARNT EIF4ENIF1 ARID2 ZMIZ2 SMARCA4 QKI | 1.97e-05 | 637 | 102 | 13 | int:SNRNP40 |
| Interaction | DCAF4 interactions | FLNA DDX17 ACACA ACACB HIPK2 EIF4ENIF1 SEC16A HELZ SPATS2 QKI | 2.20e-05 | 378 | 102 | 10 | int:DCAF4 |
| Interaction | SMARCA4 interactions | KAT6A CHD7 SSBP3 BPTF ARID1B GLI3 ARID2 ZMIZ2 SMARCA4 BICRAL BRWD1 | 2.23e-05 | 462 | 102 | 11 | int:SMARCA4 |
| Interaction | CSNK1A1 interactions | ACACA KAT6A GLI3 CGN SEC16A SMARCA4 CSTF2 FAM83G DNAJA1 PCM1 | 2.36e-05 | 381 | 102 | 10 | int:CSNK1A1 |
| Interaction | PPARG interactions | 2.60e-05 | 307 | 102 | 9 | int:PPARG | |
| Interaction | ELF4 interactions | 2.61e-05 | 115 | 102 | 6 | int:ELF4 | |
| Interaction | HOXB2 interactions | 3.22e-05 | 36 | 102 | 4 | int:HOXB2 | |
| Interaction | EYA4 interactions | 3.29e-05 | 243 | 102 | 8 | int:EYA4 | |
| Interaction | ETS1 interactions | 3.48e-05 | 121 | 102 | 6 | int:ETS1 | |
| Interaction | EYA2 interactions | 3.48e-05 | 121 | 102 | 6 | int:EYA2 | |
| Interaction | ASF1A interactions | 3.91e-05 | 249 | 102 | 8 | int:ASF1A | |
| Interaction | KLF8 interactions | 4.47e-05 | 329 | 102 | 9 | int:KLF8 | |
| Interaction | RNF113A interactions | TRERF1 FLNA DDX17 ACACA LARS1 ANKHD1 EIF4ENIF1 SEC16A HELZ SPATS2 PUM1 DNAJA1 PSPC1 | 4.64e-05 | 692 | 102 | 13 | int:RNF113A |
| Interaction | KDF1 interactions | 5.50e-05 | 192 | 102 | 7 | int:KDF1 | |
| Interaction | HSF1 interactions | FLNA NCOA6 DDX17 ACACA LARS1 SEC31A TRIM24 EIF4ENIF1 SEC16A SMARCA4 HELZ PUM1 | 5.90e-05 | 609 | 102 | 12 | int:HSF1 |
| Interaction | KLF5 interactions | 6.06e-05 | 195 | 102 | 7 | int:KLF5 | |
| Interaction | PRRC2B interactions | 6.07e-05 | 265 | 102 | 8 | int:PRRC2B | |
| Interaction | RNF43 interactions | 6.16e-05 | 427 | 102 | 10 | int:RNF43 | |
| Interaction | FAM120A interactions | 7.03e-05 | 349 | 102 | 9 | int:FAM120A | |
| Interaction | HOOK3 interactions | 7.57e-05 | 202 | 102 | 7 | int:HOOK3 | |
| Interaction | KDM1A interactions | TRERF1 TPR FLNA ACACA ACACB CHD7 ANKHD1 TRIM24 KMT2D LMAN1 EIF4ENIF1 SEC16A DNAJA1 PSPC1 PCM1 | 7.61e-05 | 941 | 102 | 15 | int:KDM1A |
| Interaction | SOX15 interactions | 8.18e-05 | 141 | 102 | 6 | int:SOX15 | |
| Interaction | KAT5 interactions | 8.54e-05 | 358 | 102 | 9 | int:KAT5 | |
| Interaction | TNIP2 interactions | TPR FLNA DDX17 WDR33 EMILIN2 SSBP3 TMEM263 ARID1B SEC16A CSTF2 HELZ PUM1 DNAJA1 PSPC1 CCDC40 | 8.67e-05 | 952 | 102 | 15 | int:TNIP2 |
| Interaction | TRIM33 interactions | FLNA DDX17 LARS1 SSBP2 SSBP3 TRIM24 BPTF ARID1B SMARCA4 UNC80 | 1.00e-04 | 453 | 102 | 10 | int:TRIM33 |
| Interaction | ELF5 interactions | 1.03e-04 | 147 | 102 | 6 | int:ELF5 | |
| Interaction | CELF1 interactions | 1.08e-04 | 288 | 102 | 8 | int:CELF1 | |
| Interaction | KLF9 interactions | 1.10e-04 | 93 | 102 | 5 | int:KLF9 | |
| Interaction | YAP1 interactions | TRERF1 TPR FLNA NCOA6 DDX17 ACACA WDR33 GLIS3 BPTF ARID1B ARNT KMT2D BRD8 ARID2 SEC16A SMARCA4 | 1.19e-04 | 1095 | 102 | 16 | int:YAP1 |
| Interaction | KLF6 interactions | 1.22e-04 | 95 | 102 | 5 | int:KLF6 | |
| Interaction | SLFN11 interactions | 1.24e-04 | 376 | 102 | 9 | int:SLFN11 | |
| Interaction | WDR5 interactions | TPR FLNA NCOA6 DDX17 ACACA ACACB KAT6A FASTKD5 CHD7 SEC31A ANKHD1 SLC30A1 MEIS2 KMT2D MBD5 PSPC1 | 1.27e-04 | 1101 | 102 | 16 | int:WDR5 |
| Interaction | NEIL3 interactions | 1.34e-04 | 97 | 102 | 5 | int:NEIL3 | |
| Interaction | TRIM28 interactions | DDX17 POLR1A ACACA WDR33 LARS1 SEC31A SSBP3 ANKHD1 TRIM24 ARNT AARS2 PPT1 ZKSCAN1 NFX1 SMARCA4 CSTF2 DNAJA1 DNAH5 DNAH8 | 1.35e-04 | 1474 | 102 | 19 | int:TRIM28 |
| Interaction | FBXW11 interactions | FLNA POLR1A TUBGCP6 EIF4ENIF1 AARS2 ZKSCAN1 GLI3 HELZ PUM1 QKI | 1.43e-04 | 473 | 102 | 10 | int:FBXW11 |
| Interaction | EIF4ENIF1 interactions | 1.43e-04 | 300 | 102 | 8 | int:EIF4ENIF1 | |
| Interaction | SMAD2 interactions | 1.48e-04 | 385 | 102 | 9 | int:SMAD2 | |
| Interaction | LHX8 interactions | 1.50e-04 | 53 | 102 | 4 | int:LHX8 | |
| Interaction | ANKRD17 interactions | 1.52e-04 | 226 | 102 | 7 | int:ANKRD17 | |
| Interaction | FXR1 interactions | FLNA ANKHD1 EIF4ENIF1 SEC16A NFX1 SMARCA4 HELZ SPATS2 PUM1 DNAJA1 PSPC1 PCM1 | 1.64e-04 | 679 | 102 | 12 | int:FXR1 |
| Interaction | TPRX2 interactions | 1.86e-04 | 56 | 102 | 4 | int:TPRX2 | |
| Interaction | GARRE1 interactions | 2.07e-04 | 167 | 102 | 6 | int:GARRE1 | |
| Interaction | CEP85 interactions | 2.20e-04 | 169 | 102 | 6 | int:CEP85 | |
| Interaction | XRCC6 interactions | TPR NCOA6 DDX17 CHD7 TRIM24 CCDC57 BPTF ARNT THRA EIF4ENIF1 NFX1 SMARCA4 MBD5 PSPC1 | 2.39e-04 | 928 | 102 | 14 | int:XRCC6 |
| Interaction | RUNX1 interactions | 2.42e-04 | 324 | 102 | 8 | int:RUNX1 | |
| Interaction | ZSWIM3 interactions | 2.51e-04 | 5 | 102 | 2 | int:ZSWIM3 | |
| Interaction | TBR1 interactions | 2.74e-04 | 113 | 102 | 5 | int:TBR1 | |
| Interaction | DTX2 interactions | 2.74e-04 | 330 | 102 | 8 | int:DTX2 | |
| Cytoband | 7q32-q34 | 4.89e-06 | 2 | 102 | 2 | 7q32-q34 | |
| GeneFamily | PHD finger proteins | 9.33e-06 | 90 | 57 | 5 | 88 | |
| GeneFamily | AT-rich interaction domain containing | 9.99e-04 | 15 | 57 | 2 | 418 | |
| GeneFamily | Dyneins, axonemal | 1.29e-03 | 17 | 57 | 2 | 536 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 4.88e-06 | 171 | 102 | 7 | M2947 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 1.31e-05 | 199 | 102 | 7 | MM991 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 1.31e-05 | 199 | 102 | 7 | M2155 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.32e-05 | 300 | 102 | 8 | M8702 | |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN | 4.72e-05 | 243 | 102 | 7 | M41178 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.72e-06 | 261 | 102 | 9 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | POLR1A WDR33 CPD SSBP2 SSBP3 ANKHD1 TRIM24 MEIS2 PPT1 AFP FAM222B SMARCA4 PUM1 QKI | 3.09e-05 | 806 | 102 | 14 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.67e-05 | 150 | 102 | 6 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.89e-05 | 379 | 102 | 9 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR NCOA6 SLC4A8 HIPK2 FASTKD5 TRIM24 BPTF PTPN4 GLI3 MBD5 QKI DNAJA1 PSPC1 SLC7A10 PCM1 CCDC40 BRWD1 | 9.69e-05 | 1257 | 102 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.00e-04 | 385 | 102 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.08e-04 | 156 | 102 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | DDX17 ACACA GLIS3 HIPK2 CPD SSBP2 CHD7 ESRP2 BPTF ZKSCAN1 AFP ARID2 BRWD1 | 1.11e-04 | 795 | 102 | 13 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 1.37e-04 | 163 | 102 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3A.Th, Lin-/lo CD25hi CD44- CD28-, Thymus, avg-3 | 1.79e-04 | 416 | 102 | 9 | GSM791146_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.82e-04 | 417 | 102 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR NCOA6 SLC4A8 HIPK2 FASTKD5 CHD7 TRIM24 BPTF PTPN4 GLI3 MBD5 QKI DNAJA1 PSPC1 SLC7A10 PCM1 CCDC40 BRWD1 | 1.88e-04 | 1459 | 102 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.64e-04 | 184 | 102 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 2.88e-04 | 66 | 102 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_500 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.33e-10 | 192 | 102 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.62e-10 | 193 | 102 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.99e-07 | 200 | 102 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-06 | 189 | 102 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.57e-06 | 199 | 102 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 143 | 102 | 5 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.02e-05 | 166 | 102 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 170 | 102 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 5.02e-05 | 174 | 102 | 5 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 5.02e-05 | 174 | 102 | 5 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.45e-05 | 177 | 102 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 6.89e-05 | 186 | 102 | 5 | 403ac98f72a42721f84fbd7826f251a88ae534a2 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.89e-05 | 186 | 102 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.89e-05 | 186 | 102 | 5 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 187 | 102 | 5 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 187 | 102 | 5 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.25e-05 | 188 | 102 | 5 | 2c4e791df69a9df29922f9117e5cac7787c129ce | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-05 | 188 | 102 | 5 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 189 | 102 | 5 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 189 | 102 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 189 | 102 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 189 | 102 | 5 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 190 | 102 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.62e-05 | 190 | 102 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.62e-05 | 190 | 102 | 5 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.20e-05 | 193 | 102 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-05 | 193 | 102 | 5 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-05 | 193 | 102 | 5 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.40e-05 | 194 | 102 | 5 | 5da8873cddff582e5693b32fd3aaebc102f65fc0 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 194 | 102 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.82e-05 | 196 | 102 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 198 | 102 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.25e-05 | 198 | 102 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.47e-05 | 199 | 102 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.47e-05 | 199 | 102 | 5 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.47e-05 | 199 | 102 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| Drug | AC1L2E0P | TRERF1 NCOA6 DDX17 KAT6A TRIM24 BRD8 THRA NFX1 SMARCA4 PSPC1 SLC7A10 | 1.34e-07 | 307 | 102 | 11 | CID000019390 |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.66e-06 | 194 | 102 | 8 | 4281_DN | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.87e-06 | 196 | 102 | 8 | 6445_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.87e-06 | 196 | 102 | 8 | 4108_DN | |
| Drug | 2-hydroxypalmitic acid | 7.19e-06 | 9 | 102 | 3 | CID000092836 | |
| Drug | prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.88e-05 | 183 | 102 | 7 | 6547_UP | |
| Drug | p-nitrophenylhydroxylamine | 1.99e-05 | 2 | 102 | 2 | CID005486551 | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.31e-05 | 189 | 102 | 7 | 6750_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.31e-05 | 189 | 102 | 7 | 3788_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A | 2.39e-05 | 190 | 102 | 7 | 2465_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A | 2.39e-05 | 190 | 102 | 7 | 7305_DN | |
| Drug | C75; Down 200; 10uM; MCF7; HT_HG-U133A | 2.55e-05 | 192 | 102 | 7 | 6423_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 2.55e-05 | 192 | 102 | 7 | 4311_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 2.73e-05 | 194 | 102 | 7 | 4320_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A | 2.73e-05 | 194 | 102 | 7 | 5342_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 2.73e-05 | 194 | 102 | 7 | 4662_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; HL60; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 2470_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 3755_DN | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 2737_DN | |
| Drug | amitriptyline hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 2.91e-05 | 196 | 102 | 7 | 167_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 6130_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 7276_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 2718_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 1518_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 3180_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; HL60; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 2336_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 2057_UP | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; PC3; HG-U133A | 3.11e-05 | 198 | 102 | 7 | 1919_DN | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.32e-05 | 200 | 102 | 7 | 4525_DN | |
| Drug | deoxycortisone | 5.94e-05 | 3 | 102 | 2 | CID000102178 | |
| Drug | Tr-B | 8.07e-05 | 51 | 102 | 4 | CID003086364 | |
| Drug | propyl gallate | 1.09e-04 | 55 | 102 | 4 | CID000004947 | |
| Drug | 4-vinylcyclohexene diepoxide | 1.11e-04 | 105 | 102 | 5 | CID000007833 | |
| Drug | KB-141 | 1.19e-04 | 4 | 102 | 2 | CID009863447 | |
| Drug | 2-hydroxyisonicotinate | 1.19e-04 | 4 | 102 | 2 | CID000280756 | |
| Drug | dimethylformamide dimethylacetal | 1.19e-04 | 4 | 102 | 2 | CID000078373 | |
| Drug | BFNU | 1.19e-04 | 4 | 102 | 2 | CID000096886 | |
| Drug | Cicloral | 1.19e-04 | 4 | 102 | 2 | CID000012628 | |
| Drug | chromium chloride | 1.19e-04 | 4 | 102 | 2 | CID000024871 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.22e-04 | 171 | 102 | 6 | 7535_DN | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.22e-04 | 171 | 102 | 6 | 3297_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.30e-04 | 173 | 102 | 6 | 5950_DN | |
| Drug | ecdysone | 1.52e-04 | 178 | 102 | 6 | CID000019212 | |
| Drug | Cpd 5 | 1.53e-04 | 60 | 102 | 4 | CID000014828 | |
| Drug | Phthalic Acids | FLNA DDX17 ACACA IREB2 SFI1 SLC30A1 BPTF ARID1B LMAN1 ARID2 CSTF2 AGTPBP1 | 1.55e-04 | 762 | 102 | 12 | ctd:D010795 |
| Drug | deferoxamine | 1.57e-04 | 343 | 102 | 8 | CID000002973 | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.71e-04 | 182 | 102 | 6 | 1280_UP | |
| Drug | croconic acid | 1.97e-04 | 5 | 102 | 2 | CID000546874 | |
| Drug | 2,3',5,5'-tetrachlorobiphenyl | 1.97e-04 | 5 | 102 | 2 | CID000038878 | |
| Drug | 4-hydroxy-2,2',5,5'-tetrachlorobiphenyl | 1.97e-04 | 5 | 102 | 2 | CID000039971 | |
| Drug | 1,3-difluoro-2-propanol | 1.97e-04 | 5 | 102 | 2 | CID000067985 | |
| Drug | diHPA | 1.97e-04 | 5 | 102 | 2 | CID000151819 | |
| Drug | gliftor | 1.97e-04 | 5 | 102 | 2 | CID000197109 | |
| Drug | AC1NSY0C | 1.97e-04 | 5 | 102 | 2 | CID005372273 | |
| Drug | p-nitroacetanilide | 1.97e-04 | 5 | 102 | 2 | CID000007691 | |
| Drug | 1,3-difluoroacetone | 1.97e-04 | 5 | 102 | 2 | CID000228397 | |
| Drug | fluoroacetaldehyde | 1.97e-04 | 5 | 102 | 2 | CID000073766 | |
| Drug | cinchoninic acid | 1.97e-04 | 5 | 102 | 2 | CID000010243 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.16e-04 | 190 | 102 | 6 | 4322_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; HL60; HT_HG-U133A | 2.16e-04 | 190 | 102 | 6 | 1286_UP | |
| Drug | oryzanol-A | 2.21e-04 | 66 | 102 | 4 | CID000089468 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.23e-04 | 191 | 102 | 6 | 4279_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.23e-04 | 191 | 102 | 6 | 3926_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.35e-04 | 193 | 102 | 6 | 5914_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.35e-04 | 193 | 102 | 6 | 4558_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.35e-04 | 193 | 102 | 6 | 6704_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 2.35e-04 | 193 | 102 | 6 | 1268_DN | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.35e-04 | 193 | 102 | 6 | 4394_DN | |
| Drug | Iohexol [66108-95-0]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.35e-04 | 193 | 102 | 6 | 3322_DN | |
| Drug | fluorocitrate | 2.36e-04 | 27 | 102 | 3 | CID000107647 | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 4319_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 1699_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 4612_DN | |
| Drug | Iopanoic acid [96-83-3]; Down 200; 7uM; HL60; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 2965_DN | |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 6913_UP | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 5571_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 5245_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 5615_DN | |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 5052_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 3333_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 2248_DN | |
| Drug | SC-560; Up 200; 10uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 6865_UP | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 7425_UP | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 7356_DN | |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 7224_DN | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 6884_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 3762_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 3448_DN | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 4491_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 2314_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 4833_UP | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 6708_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 6867_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 3311_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; HL60; HG-U133A | 2.63e-04 | 197 | 102 | 6 | 1789_UP | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 4622_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 5811_DN | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 3242_UP | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; HL60; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 1870_DN | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 7260_UP | |
| Disease | Coffin-Siris syndrome | 1.09e-05 | 13 | 101 | 3 | C0265338 | |
| Disease | Malignant Cystosarcoma Phyllodes | 1.15e-04 | 5 | 101 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 1.15e-04 | 5 | 101 | 2 | C0010701 | |
| Disease | porphyria (implicated_via_orthology) | 1.15e-04 | 5 | 101 | 2 | DOID:13268 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.15e-04 | 5 | 101 | 2 | C3281201 | |
| Disease | muscular disease (implicated_via_orthology) | 1.15e-04 | 5 | 101 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.70e-04 | 713 | 101 | 10 | EFO_0005689 | |
| Disease | dentate gyrus volume measurement | 3.25e-04 | 39 | 101 | 3 | EFO_0010083 | |
| Disease | hippocampal CA4 volume | 3.78e-04 | 41 | 101 | 3 | EFO_0009396 | |
| Disease | eosinophil count | TRERF1 FLNA CYP21A2 CHD7 SEC31A HIVEP3 BPTF LMAN1 CSF2RB SEC16A SMARCA4 MBD5 NNT SLC7A10 | 5.44e-04 | 1488 | 101 | 14 | EFO_0004842 |
| Disease | lipoprotein A measurement | 6.05e-04 | 112 | 101 | 4 | EFO_0006925 | |
| Disease | glutamine measurement, amino acid measurement | 6.25e-04 | 11 | 101 | 2 | EFO_0005134, EFO_0009768 | |
| Disease | C-reactive protein measurement | TRERF1 TRAF3IP2 NCOA6 GLS2 NUP210L CCDC168 CHD7 SSPOP BPTF ZMIZ2 SEC16A SMARCA4 | 8.59e-04 | 1206 | 101 | 12 | EFO_0004458 |
| Disease | isoleucine measurement | 9.46e-04 | 56 | 101 | 3 | EFO_0009793 | |
| Disease | anemia (implicated_via_orthology) | 1.18e-03 | 15 | 101 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | cognitive function measurement | NUP210L IREB2 SSBP2 CHD7 MEIS2 CKM ARID1B KMT2D GLI3 ZMIZ2 DNAH5 AGBL1 MOGAT3 | 1.22e-03 | 1434 | 101 | 13 | EFO_0008354 |
| Disease | eosinophil percentage of granulocytes | 1.28e-03 | 234 | 101 | 5 | EFO_0007996 | |
| Disease | basophil count, eosinophil count | 1.46e-03 | 241 | 101 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.73e-03 | 69 | 101 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.91e-03 | 19 | 101 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Osteochondrodysplasias | 1.91e-03 | 19 | 101 | 2 | C0029422 | |
| Disease | Endometrioma | 2.31e-03 | 161 | 101 | 4 | C0269102 | |
| Disease | Endometriosis | 2.31e-03 | 161 | 101 | 4 | C0014175 | |
| Disease | Bronchiectasis | 2.56e-03 | 22 | 101 | 2 | C0006267 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.58e-03 | 166 | 101 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Colorectal Carcinoma | 2.86e-03 | 702 | 101 | 8 | C0009402 | |
| Disease | diet measurement | NCOA6 SLC4A8 NUP210L GLIS3 ARID1B ARID2 SMARCA4 MBD5 DNAH5 AGBL1 | 3.20e-03 | 1049 | 101 | 10 | EFO_0008111 |
| Disease | alanine measurement | 3.24e-03 | 86 | 101 | 3 | EFO_0009765 | |
| Disease | Papillary thyroid carcinoma | 3.24e-03 | 86 | 101 | 3 | C0238463 | |
| Disease | osteonecrosis | 3.31e-03 | 25 | 101 | 2 | EFO_0004259 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NMRIIPPGSGIIHQV | 166 | P21399 | |
| PVMGQPLRDGGRQHS | 76 | Q7Z4H4 | |
| PLEMGSGQLAPRQQQ | 491 | P27540 | |
| PRNHPFVIQGDVMAN | 881 | Q8NEM8 | |
| SPVIHRSMQGGLVGN | 1121 | P0C0L5 | |
| PMIHGGEIQQTPNTV | 241 | Q9H0E9 | |
| MAGHTQQPSGRGNPR | 1 | Q9NS82 | |
| MGNHLLTNPVLQPRG | 1181 | O94910 | |
| VPQSHMFGRVQNIPA | 796 | Q68CP9 | |
| DQGQLVHMNRLPGGN | 1641 | Q13085 | |
| RMQGPGQIQTHGIPP | 1501 | Q8NFD5 | |
| PQAPQAQSLGGMHVN | 226 | P33240 | |
| RIHQIGPGMVQQIQS | 161 | P31689 | |
| QPGAPQQVMTQIIRG | 2211 | Q12830 | |
| VPMLNPDGVINGNHR | 956 | Q9UPW5 | |
| NSGQGLMHQQPIHPS | 356 | Q9P2D1 | |
| SHQPPGAMGIGQRNM | 436 | Q9P2D1 | |
| QLPQGEGGHMPVVLV | 761 | A7MBM2 | |
| PMLNPDGVINGNHRC | 841 | Q96MI9 | |
| RQIQTAVMPNGTPHP | 256 | Q96PU8 | |
| VQPGVDQRGLVQPGM | 706 | Q9H0J4 | |
| VQPGMDQRGLIQPGA | 716 | Q9H0J4 | |
| GQQGMVQPQADPHGL | 751 | Q9H0J4 | |
| NVAVIPPGTGMAHQI | 241 | P48200 | |
| PNGGIPHDNLVLIRM | 506 | P29074 | |
| PEQQPFSQMLLGHRG | 61 | Q68EN5 | |
| GNKQGPQHGMLINTP | 1681 | O00763 | |
| GHRIPQGANLQTPVM | 16 | Q8N612 | |
| GMVVHPQNPLRSGPA | 1196 | P10071 | |
| SMQHPGAGRPGQQML | 1331 | P10071 | |
| QPLNVGVAHVMRQQP | 781 | Q9H2X6 | |
| LDGQQHMGIRPAGLQ | 371 | O14770 | |
| FQVRLQPRGMGAHSP | 476 | P08686 | |
| ELMRQQNQHPEKPGG | 1081 | Q15154 | |
| LGHPQPMAQTQGLVH | 196 | Q8WU58 | |
| VQLIAAMIHPGGGRN | 2566 | Q96JB1 | |
| AMIHPGGGRNDIPQR | 2571 | Q96JB1 | |
| NAGHRNNMGPIPKDD | 271 | Q12986 | |
| GMPGQHGQITQQELD | 376 | P49257 | |
| SPSHQLQQLMVRGGP | 41 | Q6ZTU2 | |
| QQPLQQIHMGTPVPG | 461 | Q6ZTU2 | |
| GPRGAEHPNFALMQQ | 1761 | Q96RT7 | |
| LNEEGIPHNPMVNAG | 256 | Q9UI32 | |
| NMNLLQTHGRGSPIP | 1236 | P42694 | |
| PQLGQAVVIMVGGAH | 181 | Q86VF5 | |
| QQGVPGQPMNLRAEA | 521 | Q13332 | |
| QPIMVQRRPGQSFHV | 186 | Q14671 | |
| RKGDHANVNAMPRQP | 801 | Q9H158 | |
| VSSPGRNPMVQQGNV | 471 | Q14686 | |
| QGAGPPQNQMQVSHG | 561 | Q14686 | |
| PPMINLISVGGQHQG | 131 | P50897 | |
| NIGIPHTQRLQGQMP | 1836 | Q92794 | |
| APQRIPSLGVQGVMH | 381 | Q7L8L6 | |
| QVQLVPLAQAMGPGQ | 636 | P32927 | |
| IANHASPQLVGGQMP | 486 | Q6AI39 | |
| GGQMPLQQASPTVLH | 496 | Q6AI39 | |
| GNNMLLVGVHGPRTP | 2586 | P21333 | |
| GDNAVPMQHNNRPTQ | 236 | P00915 | |
| GLVNHMVVQHGLPGP | 251 | Q8NEA6 | |
| PQGQVLPMGVQHRFR | 191 | Q4G0X9 | |
| LPGRPQVKLVGNMHG | 126 | O75976 | |
| QMAPGVPGHTVTILQ | 591 | P85037 | |
| QAVQALRMHGLPRPG | 486 | Q2TAC2 | |
| GQVEGVRQMHQNAPR | 711 | Q9NSI6 | |
| TVHQIPQGDRQMRPP | 1471 | Q9P267 | |
| MILQQPLQRGPQGGA | 1 | Q9NWW0 | |
| NIQGKPHGMEGALPN | 556 | Q9BXX0 | |
| GIGRSGQQPQPLMSQ | 681 | Q92841 | |
| QNHPIPQMLNITGRG | 6101 | Q8NDH2 | |
| MIHPGGGRNDIPQRL | 2706 | Q8TE73 | |
| IRHEMTPVNPGVGQC | 486 | P02771 | |
| QVMSEGGPQPQSIVH | 1101 | Q5VU65 | |
| DVQQGADGPQHPEMV | 181 | Q9Y5H4 | |
| PGIHKTQNGVVQMPG | 1096 | P56715 | |
| MAGPGHAPLQRQLSV | 546 | A6ND36 | |
| GIHPVAGRMPGQLNV | 961 | Q13423 | |
| SQRPQKPQEHGLGMA | 1021 | A8K8P3 | |
| LPSGMDPTRQQGHPN | 156 | P81877 | |
| NGPNVHPGASMVINE | 486 | O95602 | |
| LPNSMDPTRQQGHPN | 181 | Q9BWW4 | |
| QPGHCQRVTMGPEEV | 241 | A2VEC9 | |
| VIQTGVDNPGHPFIM | 56 | P06732 | |
| HGQAESPLGIRPQQM | 616 | Q9P2J5 | |
| ARGQPLPDHLQMAVQ | 191 | P51532 | |
| LGSQPVGGQAHMVLV | 371 | P22891 | |
| MPGVPNGNVCHIEQE | 421 | Q2Y0W8 | |
| GVHMVLNQQGRPSGD | 506 | Q9H6T0 | |
| LQPLPQRHVDTGMGL | 256 | Q5JTZ9 | |
| DHPQQQPGMLSRVTG | 26 | Q8WUH6 | |
| VQRMLAQGVHPQHLP | 831 | Q9NRA8 | |
| NPRPGTPLHLAMVQQ | 886 | Q9NRA8 | |
| QIRHPRLPMAQFGGT | 1866 | Q8IWZ3 | |
| NMAEPRGPVDHGVQI | 6 | Q9P2M7 | |
| GGSQEMVQRPQPHRN | 181 | O43734 | |
| PQGQKSNDPMNQGRH | 456 | Q86XZ4 | |
| PRMQGPIQQPSISHQ | 496 | O15164 | |
| VGLPVNGDQHGNMVR | 386 | Q6NUS8 | |
| GRPSQTPEHDEQMQG | 1006 | Q8N2C7 | |
| SQVPQGHLQSMPAGN | 1051 | Q5TZJ5 | |
| HGNMPGLDRPLSRQN | 176 | O15027 | |
| AVHNDRFPQGPPSQM | 461 | Q8WXF1 | |
| RGLQLTPGIGGMQQH | 2111 | P12270 | |
| PIGGIQMVQARPGAH | 2196 | Q5T1R4 | |
| PGHRLPLQQGMTQSL | 306 | Q8NF64 | |
| RGMVPNTGQPEKQGR | 601 | Q96MP5 | |
| QLLGMHVVQGPQVRQ | 401 | P10827 | |
| QQVPGQVHGPEMLAR | 141 | P17029 | |
| RENQGPAPQGMIMGH | 791 | Q9C0J8 | |
| EPHEMQQPLVVLGVG | 106 | Q9Y6M5 | |
| PVAGHHQMPRVQTQQ | 816 | O94979 | |
| QPFHGVQQPLGQTGM | 1061 | O94979 | |
| QGGQPLQAPQMLSQH | 246 | Q96PN7 | |
| MLGPAQVAVLQQQHP | 3801 | O14686 | |
| GALGPQGPHRQVLMT | 3816 | O14686 |